自发性早产:遗传易感性发现方面的进展
家族和双生子研究证据强烈支持母体和胎儿遗传学对分娩时机及自发性早产有显著贡献,但基因发现进展有限。本文综述了炎症相关自发性早产中用于发现早产遗传变异的多种遗传学方法,包括候选基因研究、全基因组关联研究和全外显子组测序,并讨论了其局限性与前景。
要点
- 家族和双生子研究强烈支持母体和胎儿遗传学对分娩时机及自发性早产有显著贡献。
- 候选基因研究和全基因组关联研究尚未提供令人信服的早产易感DNA变异证据。
- 全外显子组测序发现先天免疫负调控基因及抗菌肽基因的罕见突变,支持早产的多基因基础。
核心结论
- 全外显子组测序和全基因组测序是识别自发性早产功能显著遗传变异最有前景的方法,至少在病理性炎症背景下如此。
- 通过全外显子组测序或全基因组测序识别早产相关基因有望产生有价值的群体特异性生物标志物,用于识别自发性早产风险及缓解该风险的潜在策略。
研究设计与样本
- 综述:回顾家族和双生子研究、候选基因研究、全基因组关联研究及全外显子组测序在炎症相关自发性早产遗传变异发现中的应用。
主要发现
- 候选基因研究寻找调节母体和胎儿炎症的遗传变异,但有希望的发现常未被重复。
- 全基因组关联研究也未产生令人信服的早产易感DNA变异证据;一项纳入超过40000名白人女性的近期全基因组关联研究显示母体位点贡献于早产,这些位点均不含直接与先天免疫相关的基因,但结果被重复。
- 近期全外显子组测序研究识别出参与先天免疫应答负调控(抑制)的基因(如CARD6、CARD8、NLRP10、NLRP12、NOD2、TLR10)及抗菌肽/蛋白基因(如DEFB1、MBL2)的罕见突变。
- 全外显子组测序识别的基因与牙周病和炎症性肠病等其他炎症状况存在重叠,提示这些状况共享遗传基础。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evidence from family and twin-based studies provide strong support for a significant contribution of maternal and fetal genetics to the timing of parturition and spontaneous preterm birth. However, there has been only modest success in the discovery of genes predisposing to preterm birth, despite increasing sophistication of genetic and genomic technology. In contrast, DNA variants associated with other traits/diseases have been identified. For example, there is overwhelming evidence that suggests that the nature and intensity of an inflammatory response in adults and children are under genetic control. Because inflammation is often invoked as an etiologic factor in spontaneous preterm birth, the question of whether spontaneous preterm birth has a genetic predisposition in the case of pathologic inflammation has been of long-standing interest to investigators. Here, we review various genetic approaches used for the discovery of preterm birth genetic variants in the context of inflammation-associated spontaneous preterm birth. Candidate gene studies have sought genetic variants that regulate inflammation in the mother and fetus; however, the promising findings have often not been replicated. Genome-wide association studies, an approach to the identification of chromosomal loci responsible for complex traits, have also not yielded compelling evidence for DNA variants predisposing to preterm birth. A recent genome-wide association study that included a large number of White women (>40,000) revealed that maternal loci contribute to preterm birth. Although none of these loci harbored genes directly related to innate immunity, the results were replicated. Another approach to identify DNA variants predisposing to preterm birth is whole exome sequencing, which examines the DNA sequence of protein-coding regions of the genome. A recent whole exome sequencing study identified rare mutations in genes encoding for proteins involved in the negative regulation (dampening) of the innate immune response (eg, CARD6, CARD8, NLRP10, NLRP12, NOD2, TLR10) and antimicrobial peptide/proteins (eg, DEFB1, MBL2). These findings support the concept that preterm labor, at least in part, has an inflammatory etiology, which can be induced by pathogens (ie, intraamniotic infection) or "danger signals" (alarmins) released during cellular stress or necrosis (ie, sterile intraamniotic inflammation). These findings support the notion that preterm birth has a polygenic basis that involves rare mutations or damaging variants in multiple genes involved in innate immunity and host defense mechanisms against microbes and their noxious products. An overlap among the whole exome sequencing-identified genes and other inflammatory conditions associated with preterm birth, such as periodontal disease and inflammatory bowel disease, was observed, which suggests a shared genetic substrate for these conditions. We propose that whole exome sequencing, as well as whole genome sequencing, is the most promising approach for the identification of functionally significant genetic variants responsible for spontaneous preterm birth, at least in the context of pathologic inflammation. The identification of genes that contribute to preterm birth by whole exome sequencing, or whole genome sequencing, promises to yield valuable population-specific biomarkers to identify the risk for spontaneous preterm birth and potential strategies to mitigate such a risk.
引用
- Strauss JF, Romero R, Gomez-Lopez N, et al. Spontaneous preterm birth: advances toward the discovery of genetic predisposition. Am J Obstet Gynecol. 2017. PMID: 29248470. doi:10.1016/j.ajog.2017.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。